Pharmacokinetic and pharmacodynamic

Pharmacokinetic and pharmacodynamic studies showed that
efalizumab produced saturation and 80% modulation of CD11a
within 24 hours of therapy.

Results (Indonesian) 1:

Pharmacokinetic dan sfat studi menunjukkan bahwaefalizumab diproduksi saturasi dan modulasi 80% CD11adalam waktu 24 jam dari terapi.

Results (Indonesian) 2:

Studi farmakokinetik dan farmakodinamik menunjukkan bahwa
efalizumab diproduksi saturasi dan 80% modulasi CD11a
dalam waktu 24 jam terapi.